An interventional study of a mixture of highly charged Lactobacilli and Bifidobacteria (VSL#3®) and levothyroxin in Hypothyroidism, sponsored by Azienda USL Modena. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2017-03-30.
Sponsored by Azienda USL Modena · Not applicable, Interventional, and Other
A prospective, randomized, single-blind, controlled, investigator-started clinical trial was carried out. Patients with primary hypothyroidism were randomly assigned to the study (VSL#3®+ LT4) and the control group (LT4). A two months treatment phase was followed by two months of follow-up. Clinical examination, blood tests for thyroid function and for peripheral tissue markers of thyroid hormones effect were performed monthly for 4 months. LT4 dose adjustments were performed during the study when necessary.
Consecutive patients on LT4 replacement therapy attending the Endocrinology Unit of Modena (Italy) were screened. According to inclusion and exclusion criteria, eighty participants were enrolled and randomized in study or control group. The random allocation sequence was generated using 'Statistical Package for the Social Sciences' software for Macintosh (SPSS) considering a 1:1 ratio by the statistician of the Unit. Clinicians evaluating and enrolling patients were blinded to the randomization list. The study design provided a monthly visit for a 4 months overall time-frame. Patients assigned to the study group took the probiotic supplement VSL#3® for two months, followed by a two months period of follow-up. Study group patients were taught to assume the probiotic supplement at least two hours after LT4 administration, to dissolve it in a cold beverage and to store it in a refrigerator (2°-8°C) in order to preserve bacteria load. The study design was single-blind since only the clinician was aware of the allocation. The VSL#3® administration was provided by nurses. Participants were invited to return all used and unused sachets to count the number of opened sachets per the number of treatment days.
All patients underwent five visits (baseline, visit 1, 2, 3 and 4) in which anthropometrical evaluation (weight and height) and hormonal function assessment were performed. A blood sample was taken in the morning at each visit, on empty stomach and before LT4 ingestion. In occurrence of hormonal alteration, LT4 daily dose was adjusted according to clinical guidelines. At baseline, visit 2 and visit 4, patients underwent clinical examination with heart rate and blood pressure evaluation. During each visit, the following data were collected: probiotic assumption, sex, age, hypothyroidism aetiology, LT4 formulation dose and brand, body mass index (BMI), body surface area (BSA), systolic blood pressure, diastolic blood pressure, heart rate, TSH, fT4, fT3 and any possible LT4 posology adjustment. All the clinical data have been further databased.
217 studies on the registry are indexed under Hypothyroidism; 50 are open to participants now.
This study's enrollment of 80 is above the median of 70 across 109 interventional studies indexed under Hypothyroidism.
Browse Hypothyroidism studies →Azienda USL Modena is the lead sponsor of 11 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The study group took a mixture of highly charged Lactobacilli and Bifidobacteria (VSL#3®) in addition to levothyroxine
Other: a mixture of highly charged Lactobacilli and Bifidobacteria (VSL#3®) · Drug: levothyroxin
The control group took levothyroxine only
Drug: levothyroxin
Patients assigned to the study group took the probiotic supplement VSL#3® for two months, in addition to levothyroxine
replacement therapy for hypothyroidism
differences in thyroid-stimulating hormone (TSH) serum levels comparing study group and controls
measurement of serum levels of thyroid-stimulating hormone (TSH) - unit of measure: microIU/mL, normal range: 0.35-4.94
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of total cholesterol (CH) - unit of measure: mg/dL, normal range: \<200
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of sex hormone-binding globulin (SHBG) - unit of measure: nmol/L, normal range: males 13.5-71.4, females 19.8-155.2
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of ferritin - unit of measure: ng/mL, normal range: 25-400
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of creatine phosphokinase (CPK) - unit of measure: U/L, normal range: 10-71
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of myoglobin - unit of measure: ng/mL, normal range: 15-106
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of osteocalcin - unit of measure: ng/mL, normal range: 4.6-65.4
Time frame: Through study completion, an average of 4 months
differences in peripheral tissue markers of thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of angiotensin-converting enzyme (ACE) - unit of measure: U/L, normal range: 8-52
Time frame: Through study completion, an average of 4 months
differences in thyroid hormones by biochemical assays comparing study group and controls
measurement of serum levels of free triiodothyronine (fT3) - unit of measure: pg/mL, normal range: 1.7-3.7; measurement of serum levels of free thyroxine (fT4) - unit of measure: pg/mL, normal range: 7-15
Time frame: Through study completion, an average of 4 months
No study locations are listed for this record.
Plan to share: Undecided
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda USL Modena